New Delhi: Drug maker Cipla Ltd is looking to make the generic version of US-based Gilead Sciences’ anti-viral drug remdesivir available in India in the next 8-10 days and price it less than Rs 5,000 per vial. Gilead Sciences extended a voluntary non-exclusive license to Cipla in May to manufacture and market Cipla’s generic version […]
Copyright © 2024 - Odisha Television Limited All Rights Reserved.